We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Micro-Imaging Technique Reveals Brain's Neuronal Networks

By Biotechdaily staff writers
Posted on 29 May 2007
Scientists have created a new imaging method called ultramicroscopy by combining two older techniques in order for researchers to view the entire brain at a microscopic level. More...


There is currently no technique available that images the entire neuronal network in an intact brain. Although computed tomography (CT) and magnetic resonance imaging (MRI) are utilized for this purpose, they do not have a cellular level resolution to reveal the micro details. Brain sectioning for microscopic imaging is a better alternative, obtaining three-dimensional (3D) images for all the multiple slices, but it is a laborious task and is highly prone for distortions.

Dr. Hans-Ulrich Dodt and colleagues, formerly at the Max Planck Institute of Psychiatry (Munich, Germany) and now at the Vienna University of Technology (Austria), reportedm that their goal was to have a method that will ultimately image all nerve cells with all their connections in the whole mouse brain. The method was published in the April 2007 issue of the journal Nature Methods.

The principle behind the method is that the brain is made translucent by putting in special oil medium, similar to a drop of oil on a paper, which makes it translucent. The organ is then illuminated only in one plane from the side with a laser. The next step involves gathering all the optical sections by a computer and finally obtaining a three-dimensional (3D) reconstruction. The technique's unique benefit is that it can be used to image large macroscopic specimens with microscopic resolution, which was not possible before.

According to Dr. Dodt, ultramicroscopy has even a wider range of applications than confocal microscopy, and therefore, the impact will be enormous. One possible application of the technique is investigation of Alzheimer's disease (AD) brains of mice. Up to now, the industry used a very labor-intensive standard--the histology to test a new Alzheimer drug on AD-modified mice. With ultramicroscopy, it should be possible to accomplish the same in one hour. Thus, it should have a big impact, as there are also other neurologic diseases and their treatment that can be investigated in 3D.

The researchers are planning to obtain brain scans of both mouse embryos and adult mice. They hope to gain better knowledge about how mammalian brain networks change during development and learning. This could not only give key insights about how mammalian brains evolve over time but also about how information networks are affected or altered in disease states.


Related Links:
Vienna University of Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.